Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells.

作者: Kayla EA Duval , Nicholas A Vernice , Robert J Wagner , Steven N Fiering , James D Petryk

DOI: 10.1080/02656736.2019.1627433

关键词:

摘要: Objective: In this in vitro study we have used an RNA quantification technique, nanoString, and a conventional protein analysis technique (Western Blot) to assess the genetic expression of B16 murine melanoma cells following modest magnetic nanoparticle hyperthermia (mNPH) dose equivalent 30 minutes @ 43°C (CEM43 30) and/or clinically relevant 8 Gy radiation dose.Methods: Melanoma with mNPs(2.5 μg Fe/106 cells) were pelleted exposed alternating field (AMF) generate targeted thermal dose. Thermal was accurately monitored by fiber optic probe automatically maintained at CEM43 30. All harvested 24 hours after treatment.Results: The mNPH demonstrated notable elevations thermotolerance/immunogenic HSP70 gene number chemoattractant toll-like receptor pathways. also upregulated important immune cytotoxic However, mNPH/radiation combination most effective stimulator wide variety genes including HSP70, cancer regulating chemokines CXCL10, CXCL11, T-cell trafficking chemokine CXCR3, innate activators TLR3, TLR4, MDM2 mTOR negative regulator p53, pro-apoptotic PUMA, cell death Fas. Importantly changes validated changes, i.e., p-mTOR, p-MDM2.Conclusion: These results not only show that low independently increase but effect is greatly enhanced when they are combination.

参考文章(25)
H. S. Mostowski, D. S. A. Webb, T. L. Gerrard, Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. Journal of Immunology. ,vol. 146, pp. 3682- 3686 ,(1991)
M.R. Horsman, J. Overgaard, Hyperthermia: a potent enhancer of radiotherapy. Clinical Oncology. ,vol. 19, pp. 418- 426 ,(2007) , 10.1016/J.CLON.2007.03.015
Wei Chen, Jun Zhang, Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. Journal of Nanoscience and Nanotechnology. ,vol. 6, pp. 1159- 1166 ,(2006) , 10.1166/JNN.2006.327
Magdalena Karbowniczek, Cynthia S. Spittle, Tasha Morrison, Hong Wu, Elizabeth P. Henske, mTOR Is Activated in the Majority of Malignant Melanomas Journal of Investigative Dermatology. ,vol. 128, pp. 980- 987 ,(2008) , 10.1038/SJ.JID.5701074
Teiji Wada, Josef M Penninger, Mitogen-activated protein kinases in apoptosis regulation. Oncogene. ,vol. 23, pp. 2838- 2849 ,(2004) , 10.1038/SJ.ONC.1207556
Susan Elmore, Apoptosis: A Review of Programmed Cell Death Toxicologic Pathology. ,vol. 35, pp. 495- 516 ,(2007) , 10.1080/01926230701320337
Weigang He, Qiuyan Liu, Li Wang, Wei Chen, Nan Li, Xuetao Cao, TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Molecular Immunology. ,vol. 44, pp. 2850- 2859 ,(2007) , 10.1016/J.MOLIMM.2007.01.022
Konstantinos G. Lasithiotakis, Tobias W. Sinnberg, Birgit Schittek, Keith T. Flaherty, Dagmar Kulms, Evelyn Maczey, Claus Garbe, Friedegund E. Meier, Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells Journal of Investigative Dermatology. ,vol. 128, pp. 2013- 2023 ,(2008) , 10.1038/JID.2008.44
Li Yu, Shangwu Chen, Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunology, Immunotherapy. ,vol. 57, pp. 1271- 1278 ,(2008) , 10.1007/S00262-008-0459-8
Vladislava O Melnikova, Svetlana V Bolshakov, Christopher Walker, Honnavara N Ananthaswamy, Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines. Oncogene. ,vol. 23, pp. 2347- 2356 ,(2004) , 10.1038/SJ.ONC.1207405